Fixed-Duration Epcoritamab Combination Therapy for Relapsed or Refractory Follicular Lymphoma and Pre-Transplant Strategies for GVHD post-HSCT
Dr. Laurie Sehn interviews Drs. Lorenzo Falchi and Robert Levy about their Blood Journal papers. Dr. Falchi discusses epcoritamab for follicular lymphoma, and Dr. Levy presents findings on Treg expansion to ameliorate GVHD post-HSCT, both showing promising results.